Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-08-14Clinical Trial Update: Neoadjuvant HS-10296 (Almonertinib) Therapy for Potential Resectable Stage III EGFR Mutation-Positive Non-small Cell Lung Cancer [Phase 2]
A Phase 2 neoadjuvant trial is evaluating almonertinib (HS-10296) for potentially resectable stage III EGFR-mutant non-small cell lung cance…
-
CLINICAL_TRIALS research · 2024-08-12Clinical Trial Update: Dietary Intervention for NSCLC Patients Treated With ICI [NA]
A clinical trial evaluating a dietary intervention in patients with non-small cell lung cancer who are treated with immune checkpoint inhibi…
-
CLINICAL_TRIALS research · 2024-08-09Clinical Trial Update: Alectinib in Neo-adjuvant Treatment of Stage III NSCLC [Phase 2]
Phase 2 trial evaluating neoadjuvant alectinib for stage III non-small cell lung cancer. The study is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2024-08-09Clinical Trial Update: Improving Osimertinib Exposure and Cost-effectiveness Using Pharmacokinetic Boosting With Cobicistat [Phase 4]
A Phase 4 clinical trial from Maastricht University Medical Center will evaluate boosting osimertinib exposure with cobicistat to improve dr…
-
CLINICAL_TRIALS research · 2024-08-09Clinical Trial Update: Prognostic Value of Combined Approach Based on KEAP1/NFE2L2 Mutations and Pre-therapeutic FDG-PET/CT Radiomic Analysis in Advanced Non-small-cell Lung Cancer PDL1 ≥ 50% Treated With Pembrolizumab (PEMBROMIC)
This clinical trial update evaluates whether a combined KEAP1/NFE2L2 mutation profile and pre-treatment FDG-PET/CT radiomic analysis can pro…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-08-09Clinical Trial Update: ERectile Dysfunctions, gOnadotoxicity and Sexual Health Assessment in Men With Lung Cancer
Clinical trial update investigating erectile dysfunction, gonadotoxicity, and sexual health in men with non-small cell lung cancer (Stage IV…
-
CLINICAL_TRIALS research · 2024-08-09Clinical Trial Update: Surveillance With PET/CT and Liquid Biopsies of Stage I-III Lung Cancer Patients After Completion of Definitive Therapy [NA]
This clinical trial update describes surveillance using PET/CT scans and liquid biopsies for stage I-III non-small cell lung cancer after de…
-
CLINICAL_TRIALS research · 2024-08-07Clinical Trial Update: Fecal Microbial Transplantation Non-Small Cell Lung Cancer and Melanoma [Phase 2]
Clinical trial update for a Phase 2 study evaluating fecal microbiota transplantation in metastatic non-small cell lung cancer and advanced …
-
CLINICAL_TRIALS research · 2024-08-07Clinical Trial Update: Prediction of Mediastinal Station IV Lymph Node Metastasis in Non-small Cell Lung Cancer
This trial, sponsored by Qilu Hospital of Shandong University, aims to predict mediastinal station IV lymph node metastasis in non-small cel…
-
CLINICAL_TRIALS research · 2024-08-06Clinical Trial Update: A Multicenter Randomized Controlled Study of Interventional Treatment for Operable Stage Ⅱ-Ⅲ Non-small Cell Lung Cancer With Potential Recurrence as Minimal Residual Disease(MRD) Positive [Phase 2]
A Phase 2 multicenter randomized trial evaluating an interventional treatment for operable stage II–III non-small cell lung cancer with mini…
-
CLINICAL_TRIALS research · 2024-08-06Clinical Trial Update: Perceptions on Expected Outcomes of Immunotherapy in Advanced Cancer Patients With Poor Performance Status
Clinical trial update examining perceptions of immunotherapy outcomes in advanced cancer patients with poor performance status, focusing on …
-
CLINICAL_TRIALS research · 2024-08-05Clinical Trial Update: Osimertinib and Abemaciclib in EGFR Mutant Non-Small Cell Lung Cancer After Osimertinib Resistance [Phase 2]
A Phase 2 clinical trial is evaluating the combination of osimertinib and abemaciclib in patients with EGFR-mutant non-small cell lung cance…
-
CLINICAL_TRIALS research · 2024-08-02Clinical Trial Update: Milaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study [Phase 2]
Open-phase 2 multicenter trial evaluating Milaberon in advanced solid tumors across multiple indications, currently recruiting.
-
CLINICAL_TRIALS research · 2024-08-02Clinical Trial Update: Surgical Strategy of NSCLC Patients After Neo-adjuvant or Induction Treatment
This clinical trial update notes an ongoing study from Ruijin Hospital assessing surgical strategies for patients with non-small cell lung c…
-
CLINICAL_TRIALS research · 2024-07-31Clinical Trial Update: Surufatinib or Surufatinib Combined With Vinorelbine for Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating Surufatinib alone or in combination with Vinorelbine for advanced Non-Small Cell Lung Cancer; current trial status …
-
CLINICAL_TRIALS research · 2024-07-31Clinical Trial Update: Longitudinal Assessment of Genomic Alterations and Clonal Evolution in ALK-positive NSCLC (Galileo Project)
The Galileo Project is a longitudinal study investigating genomic alterations and clonal evolution in ALK-positive non-small cell lung cance…
-
CLINICAL_TRIALS research · 2024-07-31Clinical Trial Update: Adjuvant Benmelstobart for Stage IB, Grade 3 Invasive Lung Adenocarcinoma [Phase 2]
Phase 2 trial evaluating adjuvant Benmelstobart for Stage IB, Grade 3 invasive lung adenocarcinoma (non-small cell lung cancer) is currently…
-
CLINICAL_TRIALS research · 2024-07-31Clinical Trial Update: A Study to Evaluate the Efficacy of Osimertinib in Patients With EGFR-sensitive Mutated Non-small Cell Lung Cancer Progression After Receiving Adjuvant Targeted Therapy Following Radical Surgery [Phase 2]
Phase 2 study evaluating Osimertinib in patients with EGFR-mutated non-small cell lung cancer who progressed after adjuvant targeted therapy…
-
CLINICAL_TRIALS research · 2024-07-30Clinical Trial Update: A Phase II Study of SSGJ-707 Combination Therapy in Advanced NSCLC Patients [Phase 2]
A Phase II trial evaluating SSGJ-707 in combination therapy for first-line, advanced non-small cell lung cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2024-07-30Clinical Trial Update: From Benchmark to Surgical Activity: the Role of Endobronchial Fiducial Markers for Ground Glass Lung Nodules Resection.
Clinical trial update describing the potential role of endobronchial fiducial markers in guiding surgical resection of ground-glass lung nod…
-
CLINICAL_TRIALS research · 2024-07-29Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of the Combination of Glumetinib and Docetaxel（Albumin Bound）Verse Docetaxel for the Treatment of MET-overexpressed Non-small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial registry entry evaluating the combination of glumetinib and albumin-bound docetaxel versus docetaxel alone for MET-…
-
CLINICAL_TRIALS research · 2024-07-26Clinical Trial Update: High-dose Furmonertinib in the Treatment in Patients With Advanced, Metastatic NSCLC With Progressed After First- or Second-line Treatment With Osimertinib [Phase 2]
A Phase 2 clinical trial evaluating high-dose furmonertinib for advanced, metastatic non-small cell lung cancer in patients who progressed a…
-
CLINICAL_TRIALS research · 2024-07-25Clinical Trial Update: Prognostic Significance of the Uncertain Resection in NSCLC
Update on a clinical trial assessing how uncertain resection affects prognosis in non-small cell lung cancer; the study is currently active …
-
CLINICAL_TRIALS research · 2024-07-25Clinical Trial Update: Befotertinib and Icotinib for NSCLC With Uncommon EGFR Mutations [Phase 2]
Phase 2 trial evaluating Befotertinib and Icotinib for metastatic non-small cell lung cancer with uncommon EGFR mutations (G719X, L861Q, S76…
-
CLINICAL_TRIALS research · 2024-07-24Clinical Trial Update: Efficacy and Safety of High-Dose Rate Brachytherapy With Immunotherapy and Chemotherapy as Second-Line Treatment for Advanced Non-Small Cell Lung Cancer
A clinical trial is evaluating high-dose rate brachytherapy combined with immunotherapy and chemotherapy as a second-line treatment for adva…